FDA Won’t Require Study Sponsors to Report Suspected Misconduct

October 24, 2018

Drug and device companies no longer have to worry about getting hit with a Food and Drug Administration (FDA) enforcement action if they do not promptly report suspected data fudging in a study they sponsor.

Related Stories